Blood groups are classified based on inherited carbohydrate or protein molecules located on the surface of red blood cells, known as antigens. When foreign blood enters a recipient's system, the immune system examines these unfamiliar antigens. If the host plasma contains corresponding antibodies against the donor antigens, an immune response triggers red blood cell destruction, leading to agglutination and hemolysis. Understanding these surface markers forms the biochemical foundation of safe transfusion practice in clinical nursing.
Because Group O red blood cells lack A and B antigens, they are historically termed universal red cell donors. Conversely, individuals with Group AB are considered universal plasma recipients because their blood contains no naturally occurring ABO antibodies to attack incoming donor plasma.
The Rhesus system centers primarily on the D antigen. Individuals possessing this surface protein are designated as Rh-positive, while those lacking it are Rh-negative. Unlike ABO antibodies, which develop naturally in early childhood without prior exposure, anti-Rh antibodies only form after direct sensitization through pregnancy or blood transfusion.
In Nigerian obstetric practice, screening for Rh incompatibility is vital. An Rh-negative mother carrying an Rh-positive fetus can develop anti-D antibodies during delivery or minor placental bleeding. During subsequent pregnancies with another Rh-positive baby, these maternal antibodies cross the placenta and cause hemolytic disease of the newborn.
Blood typing involves mixing a patient's blood sample with known commercial antiserum containing specific antibodies—anti-A, anti-B, and anti-D. If agglutination occurs, the corresponding antigen is present on the red blood cells. For instance, clumping with anti-A serum and anti-D serum indicates blood group A positive. Nurses must meticulously verify these laboratory findings against patient wristbands and request forms before requesting cross-matched units from the blood bank.
Cross-matching is the final pre-transfusion safety check. It involves combining the recipient's serum with the donor's red blood cells to detect any hidden or unexpected antibodies that could cause a transfusion reaction. The procedure typically includes immediate spin testing for ABO compatibility and an indirect antiglobulin test (Coombs test) to check for minor blood group antibodies. Skipping this step or rushing the process increases the risk of acute hemolytic reactions.
| Cross-Match Type | Mixtures Used | Clinical Objective |
|---|---|---|
| Major Cross-Match | Recipient serum + Donor red blood cells | Detects recipient antibodies attacking donor cells |
| Minor Cross-Match | Donor serum + Recipient red blood cells | Detects donor antibodies attacking recipient cells |
In modern blood banking, major cross-matching is mandatory for every cellular blood product. Minor cross-matching is performed less frequently today because donor plasma is largely removed from packed red cell concentrates, though it remains relevant when transfusing whole blood or plasma products containing active antibodies.
Safe blood administration requires strict adherence to clinical protocol. Two qualified nurses must independently verify patient identification details, blood group, unit serial number, and expiration date against the prescription chart and blood bag label at the bedside. Baseline vital signs are recorded before starting the transfusion, repeated fifteen minutes after initiation, and monitored hourly until completion. The first fifteen minutes demand intense observation because most acute hemolytic reactions manifest during the infusion of the initial milliliters of blood.
Blood transfusions carry risks ranging from mild allergic episodes to life-threatening emergencies. Acute hemolytic reactions present with fever, chills, loin pain, and hypotension, requiring immediate cessation of the transfusion and infusion of normal saline to maintain renal perfusion. Other potential complications include febrile non-hemolytic reactions, circulatory overload, bacterial contamination, and transfusion-related acute lung injury (TRALI). Nurses must recognize early signs of distress, stop the infusion immediately while keeping the intravenous line open with a new infusion set, and notify the medical team.